Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
December 12, 2023
It's making a major acquisition to beef up a key area of its pipeline.
Via
The Motley Fool
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)
Via
Benzinga
AbbVie continues shopping spree with biotech buyout
December 12, 2023
While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend.
Via
MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc.
December 11, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Is AbbVie Stock a Buy Now?
December 07, 2023
AbbVie's business could soon become more diversified.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
Via
Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
Investors wanting to buy low and sell high should consider a position in one of these great companies whose shares have pulled back lately.
Via
InvestorPlace
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH
December 10, 2023
From
ImmunoGen Inc.
Via
Business Wire
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
The big drugmaker went on a holiday shopping spree.
Via
The Motley Fool
Market Movers: Why Big Players Are Investing Millions in These 3 Stocks
December 08, 2023
In investing, certain stocks catch the discerning eye of big players, drawing in substantial investments.
Via
InvestorPlace
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
December 08, 2023
Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.
Via
The Motley Fool
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
December 07, 2023
TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93.
Via
Investor's Business Daily
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Wednesday, AbbVie Inc (NYSE: ABBV) agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for a total equity value of approximately $8.7 billion, or $45 per share in cash, with the...
Via
Benzinga
Regeneron Pharmaceuticals Stock Sees A Relative Strength Rating Rise
December 06, 2023
Regeneron Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
December 06, 2023
The Russell 2000 index comprises small-cap companies, exposing investors to small organizations. Consider buying these Russell 2000 stocks.
Via
InvestorPlace
FDA Grants Priority Review of ImmunoGen’s Supplemental Biologics License Application for ELAHERE® (mirvetuximab soravtansine-gynx) in Platinum-Resistant Ovarian Cancer
December 05, 2023
From
ImmunoGen, Inc.
Via
Business Wire
IMMUNOGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ImmunoGen, Inc. - IMGN
December 04, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
December 04, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
ImmunoGen, AbbVie's $10B Deal Comes At 'Right Time' Analyst Says In Downgrade Note
December 04, 2023
AbbVie Inc (NYSE: ABBV) is acquiring ImmunoGen, Inc. (NASDAQ: IMGN) for around $
Via
Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
December 01, 2023
Software earnings were strong, while the Fed is shifting toward rate cuts.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
December 01, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Via
Talk Markets
Why Abbvie Stock Popped Today
November 30, 2023
The company announces a major deal worth over $10 billion.
Via
The Motley Fool
Nasdaq Falls Over 100 Points; Cracker Barrel Shares Slide After Q1 Results
November 30, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 30, 2023
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 30, 2023
Via
Benzinga
Crude Oil Falls Sharply; Kroger Posts Upbeat Earnings
November 30, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal
November 30, 2023
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC)...
Via
Benzinga
Why Is Soligenix (SNGX) Stock Up 285% Today?
November 30, 2023
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.